• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Alcohol-related liver disease: Time for action.酒精性肝病：行动时刻。
J Hepatol. 2019 Feb;70(2):221-222. doi: 10.1016/j.jhep.2018.12.007.
2
Alcohol and Liver Transplantation.酒精与肝移植
Alcohol Alcohol. 2017 Jan;52(1):126. doi: 10.1093/alcalc/agw056. Epub 2016 Sep 5.
3
Reply to ''Alcohol and Liver Transplantation''.对《酒精与肝移植》的回复。
Alcohol Alcohol. 2017 Jan;52(1):127. doi: 10.1093/alcalc/agw057. Epub 2016 Sep 5.
4
Does Intestinal Microbiota Protect Mice Against Acute/Binge Drinking-Induced Liver Injury?肠道微生物群能保护小鼠免受急性/暴饮诱导的肝损伤吗？
Alcohol Clin Exp Res. 2016 Aug;40(8):1788-90. doi: 10.1111/acer.13130. Epub 2016 Jun 24.
5
High-Intensity Drinking Versus Heavy Episodic Drinking: Prevalence Rates and Relative Odds of Alcohol Use Disorder Across Adulthood.高度饮酒与重度间歇性饮酒：成年期酒精使用障碍的患病率和相对比值。
Alcohol Clin Exp Res. 2017 Oct;41(10):1754-1759. doi: 10.1111/acer.13475. Epub 2017 Sep 5.
6
Monitoring for alcohol use relapse after liver transplantation for alcoholic liver disease.对酒精性肝病肝移植术后酒精使用复发情况的监测。
Liver Transpl Surg. 1997 May;3(3):300-3. doi: 10.1002/lt.500030317.
7
Trends in Adult Alcohol Use and Binge Drinking in the Early 21st-Century United States: A Meta-Analysis of 6 National Survey Series.21 世纪初美国成年人饮酒和狂饮趋势的元分析：6 项全国调查系列研究
Alcohol Clin Exp Res. 2018 Oct;42(10):1939-1950. doi: 10.1111/acer.13859. Epub 2018 Aug 23.
8
Alcoholic liver disease: a public health issue in need of a public health approach.酒精性肝病：一个需要公共卫生方法来解决的公共卫生问题。
Semin Liver Dis. 1993 May;13(2):105-7.
9
The natural history of alcoholism and its relationship to liver transplantation.酒精中毒的自然史及其与肝移植的关系。
Liver Transpl Surg. 1997 May;3(3):304-10. doi: 10.1002/lt.500030318.
10
Alcoholic liver disease and pancreatitis: global health problems being addressed by the US National Institute on Alcohol Abuse and Alcoholism.酒精性肝病和胰腺炎：美国国家酒精滥用和酒精中毒研究所解决的全球健康问题。
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:4-6. doi: 10.1111/jgh.12246.

引用本文的文献

1
Impact of GLP-1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol-Associated Liver Disease and Type 2 Diabetes.胰高血糖素样肽-1受体激动剂对酒精性肝病合并2型糖尿病患者不良肝脏结局风险的影响
Liver Int. 2025 Apr;45(4):e16132. doi: 10.1111/liv.16132. Epub 2024 Oct 15.
2
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis.Meta 分析：酒精性肝硬化中戒酒的流行情况和影响。
Aliment Pharmacol Ther. 2024 Mar;59(6):730-741. doi: 10.1111/apt.17888. Epub 2024 Feb 1.
3
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments.酒精相关性肝病：不断变化的概念与治疗。
Drugs. 2023 Nov;83(16):1459-1474. doi: 10.1007/s40265-023-01939-9. Epub 2023 Sep 25.
4
Click chemistry-based thiol redox proteomics reveals significant cysteine reduction induced by chronic ethanol consumption.基于点击化学的巯基氧化还原蛋白质组学揭示慢性乙醇摄入诱导的显著半胱氨酸还原。
Redox Biol. 2023 Aug;64:102792. doi: 10.1016/j.redox.2023.102792. Epub 2023 Jun 22.
5
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New Zealand.隐匿性流行病：澳大利亚和新西兰肝移植患者中并发肝病的患病率及影响
Transplant Direct. 2022 Jul 15;8(8):e1345. doi: 10.1097/TXD.0000000000001345. eCollection 2022 Aug.
6
Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice.工程化生产芳烃受体激动剂的细菌可预防小鼠酒精性肝病。
Alcohol Clin Exp Res (Hoboken). 2023 May;47(5):856-867. doi: 10.1111/acer.15048. Epub 2023 Mar 19.
7
Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C.脂滴相关蛋白 perilipin 1 和 2：慢性丙型肝炎脂肪变性和微泡性脂肪变性灶的分子标志物。
Int J Mol Sci. 2022 Dec 7;23(24):15456. doi: 10.3390/ijms232415456.
8
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder.针对酒精使用障碍治疗中未满足的临床需求。
Front Psychiatry. 2022 Jun 9;13:767506. doi: 10.3389/fpsyt.2022.767506. eCollection 2022.
9
Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.酒精性肝病进展的肝脏特异性、系统性和遗传因素。
Z Gastroenterol. 2022 Jan;60(1):36-44. doi: 10.1055/a-1714-9330. Epub 2022 Jan 18.
10
Role of cell-free network communication in alcohol-associated disorders and liver metastasis.无细胞网络通讯在酒精相关疾病和肝转移中的作用。
World J Gastroenterol. 2021 Nov 7;27(41):7080-7099. doi: 10.3748/wjg.v27.i41.7080.

本文引用的文献

1
Liver transplantation for alcoholic hepatitis.酒精性肝炎的肝移植。
J Hepatol. 2019 Feb;70(2):328-334. doi: 10.1016/j.jhep.2018.11.007.
2
Acute-on-chronic liver failure in patients with alcohol-related liver disease.酒精性肝病患者的慢加急性肝衰竭。
J Hepatol. 2019 Feb;70(2):319-327. doi: 10.1016/j.jhep.2018.12.008.
3
Endpoints and patient stratification in clinical trials for alcoholic hepatitis.酒精性肝炎临床试验的终点和患者分层。
J Hepatol. 2019 Feb;70(2):314-318. doi: 10.1016/j.jhep.2018.11.005.
4
Current trials and novel therapeutic targets for alcoholic hepatitis.目前治疗酒精性肝炎的试验和新的治疗靶点。
J Hepatol. 2019 Feb;70(2):305-313. doi: 10.1016/j.jhep.2018.10.026.
5
Fibrosis and alcohol-related liver disease.纤维化与酒精性肝病。
J Hepatol. 2019 Feb;70(2):294-304. doi: 10.1016/j.jhep.2018.12.003.
6
Hepatocellular carcinoma in the setting of alcohol-related liver disease.酒精性肝病背景下的肝细胞癌。
J Hepatol. 2019 Feb;70(2):284-293. doi: 10.1016/j.jhep.2018.10.008.
7
Non-invasive diagnosis and biomarkers in alcohol-related liver disease.酒精性肝病的无创诊断和生物标志物。
J Hepatol. 2019 Feb;70(2):273-283. doi: 10.1016/j.jhep.2018.11.025.
8
Microbiome as a therapeutic target in alcohol-related liver disease.肠道菌群作为酒精性肝病的治疗靶点。
J Hepatol. 2019 Feb;70(2):260-272. doi: 10.1016/j.jhep.2018.10.019.
9
Inflammatory pathways in alcoholic steatohepatitis.酒精性脂肪性肝炎中的炎症通路。
J Hepatol. 2019 Feb;70(2):249-259. doi: 10.1016/j.jhep.2018.10.023.
10
Effect of ethanol on lipid metabolism.乙醇对脂代谢的影响。
J Hepatol. 2019 Feb;70(2):237-248. doi: 10.1016/j.jhep.2018.10.037.

Alcohol-related liver disease: Time for action.

作者信息

Bataller Ramon, Arteel Gavin E, Moreno Christophe, Shah Vijay

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, USA.

Division of Gastroenterology, Hepatology and Nutrition, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

J Hepatol. 2019 Feb;70(2):221-222. doi: 10.1016/j.jhep.2018.12.007.

DOI:10.1016/j.jhep.2018.12.007
PMID:30658723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6416779/
Abstract
摘要